Unimark Remedies Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their notable products is TIGECYCLINE TECHNICAL, with a corresponding US DMF Number 22247.
Remarkably, this DMF maintains an Active status since its submission on November 29, 2008, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of January 09, 2013, and payment made on December 10, 2012, indicating their dedication to facilitating drug approvals, Categorized as Type II